Teva Pharmaceutical Industries TEVA
NYSE TEVA
$39.56 -0.24 (-0.60%)
At close: Sep 30, 2026 · 4:00 PM EDT

Teva Pharmaceutical Industries (TEVA) Change in Receivables (2025 - 2026)

Updated

Teva Pharmaceutical Industries' Change in Receivables was $91 million in Q2 2026, down 18.0% from $111 million a year earlier.

Analysis

Teva Pharmaceutical Industries (TEVA) Change in Receivables (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Teva Pharmaceutical Industries' Change in Receivables was -$140 million through Jun 30, 2026; for FY2025, it was -$173 million.

  • In earlier years, Change in Receivables was $245 million in FY2024, $12 million in FY2023 (-96.4%), $334 million in FY2022 and -$574 million in FY2021.
  • Quarterly Change in Receivables has moved between -$264 million (Q1 2025) and $111 million (Q2 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.35 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.37 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.09 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 333.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 140.20 Mn
10 Teva Pharmaceutical Industries 46.10 Bn 32.95 Bn 2.15 Bn 91.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 91.00 Mn
Mar 31, 2026 -78.00 Mn
Jun 30, 2025 111.00 Mn
Mar 31, 2025 -264.00 Mn
API Access

Teva Pharmaceutical Industries Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TEVA&period=max&api_key=YOUR_API_KEY